Compugen (CGEN) Non Operating Income (2009 - 2026)

Compugen recorded quarterly Non Operating Income of $1.4 million in Q1 2026, up 8.67% quarter-over-quarter from $1.2 million in Q1 2025, and up 8.67% year-over-year from $1.2 million in Q1 2025.

Compugen's Non Operating Income history runs 2 years deep, the most recent figure standing at $1.4 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 444,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 201.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -46.98 Mn
10 Compugen 234.03 Mn 142.28 Mn 352,000.00 1.35 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.35 Mn
Dec 31, 2025 802,000.00
Sep 30, 2025 954,000.00
Jun 30, 2025 1.07 Mn
Mar 31, 2025 1.25 Mn
Dec 31, 2024 1.37 Mn
Sep 30, 2024 1.28 Mn
Jun 30, 2024 1.30 Mn
Mar 31, 2024 1.23 Mn
Dec 31, 2023 735,000.00
Sep 30, 2023 776,000.00
Jun 30, 2023 889,000.00
Mar 31, 2023 808,000.00
Dec 31, 2022 495,000.00
Sep 30, 2022 464,000.00
Jun 30, 2022 493,000.00
Mar 31, 2022 286,000.00
Dec 31, 2021 135,000.00
Sep 30, 2021 177,000.00
Jun 30, 2021 200,000.00
Mar 31, 2021 359,000.00
Dec 31, 2020 528,000.00
Sep 30, 2020 464,000.00
Jun 30, 2020 536,000.00
Mar 31, 2020 270,000.00
Dec 31, 2019 232,000.00
Sep 30, 2019 174,000.00
Jun 30, 2019 308,000.00
Mar 31, 2019 106,000.00
Dec 31, 2018 277,000.00
Sep 30, 2018 221,000.00
Dec 31, 2017 76,000.00
Sep 30, 2017 108,000.00
Dec 31, 2016 245,000.00
Sep 30, 2016 186,000.00
Mar 31, 2010 -1,000.00
Mar 31, 2009 -243,000.00